Objectives: To investigate whether measured glomerular filtration rate (mGFR) is a risk factor for death and/or end-stage renal disease (ESRD) after heart transplantation (HTx).
Survival after HTx of patients stratified for preoperative mGFR. There was no significant difference in long-term survival among patients with a preoperative mGFR <30 (group 1), those with an mGFR between 30 and 60 mL/min/1.73 m 2 (group 2), and those with an mGFR !60 mL/min/1.73 m 2 (group 3) (P ¼ .60, log-rank test).
Central Message
Pretransplantation kidney function, based on measured glomerular filtration rate (mGFR), was not predictive of mortality or end-stage renal disease. However, a decrease in mGFR by>25% during the first year, along with early postoperative dialysis, were associated with worse survival after heart transplantation.
Perspective
Debate is ongoing about the level of kidney function considered a contraindication for heart transplantation (HTx). When carefully selected patients with poor preoperative kidney function were offered HTx (simultaneous or late kidney transplantation when needed), their prognosis was not worse than others. Prognosis was poor in patients who received dialysis in an intensive care unit during the index hospitalization and those who experienced a pronounced drop in measured glomerular filtration rate (>25%) during the first year.
See Editorial Commentary page 1605.
From the Departments of a Cardiothoracic Surgery, Heart transplantation (HTx) is an established treatment with excellent outcome in patients with end-stage heart failure. 1 However, impaired renal function is a well-described complication on both short-and long-term follow-up after HTx and other organ transplantation. 2, 3 Furthermore, postoperative deterioration of renal function has been identified as an important risk factor for long-term mortality after HTx. 3 Controversy persists regarding the exact level at which a reduced glomerular filtration rate (GFR) should be considered a major risk factor for HTx. At the 24th Bethesda Conference in 1993, a creatinine clearance <50 mL/min was a considered secondary exclusion criterion for HTx. 4 In 2006, the International Society of Heart and Lung Transplantation recommended that a pretransplantation GFR of 40 mL/min/1.73 m 2 be considered a relative contraindication for HTx. 5 In the Society's 2016 guidelines, this cutoff was further reduced to <30 mL/min/1.73 m 2 . 6 We have long performed simultaneous or delayed kidney transplantation (KTx) in patients with severely reduced GFR.
We recently demonstrated that 3 of the most widely used equations for calculating estimated GFR (eGFR) agree poorly with measured GFR (mGFR) in patients undergoing HTx. 7 In light of this, we reviewed our experience with renal function before and after HTx in our complete cohort of Htx recipients. This cohort is unique because all patients had both a pretransplantation workup and annual follow-up with mGFR assessment. The primary aim of our present analysis was to evaluate mGFR over time and to identify pretransplantation risk factors and the effect of early posttransplantation renal dysfunction on long-term mortality and the development of end-stage renal disease (ESRD) after HTx. The secondary aim was to evaluate the impact of ESRD on mortality after HTx and to establish risk factors for the development dialysis-dependent acute renal failure and ESRD.
PATIENTS AND METHODS Patient Population
Between January 1, 1988, and December 31, 2010, a total of 478 patients, including 416 adults (age !18 years) and 62 were pediatric patients (age <18 years), underwent HTx at Sahlgrenska University Hospital. All adult patients (age range, 18-70 years) were included in this study, but for the 13 patients who underwent retransplantation, only data from the first transplantation were analyzed. A flow chart illustrating patient inclusion and exclusion criteria is shown in Figure 1 , and patient characteristics are summarized in Table 1 . The average duration of follow-up was 8.9 years (range, 1-26 years). No patient was lost during follow-up. Approval for the study was obtained from the Institutional Review Board at the University of Gothenburg.
Surgical Procedure
All surgeries were performed via a median sternotomy with extracorporeal circulation. A biatrial technique was initially used, but between 1995 and 1998 this was gradually changed to a bicaval technique. 8 Over time, the complexity of surgery has increased as more patients with a history of previous heart surgery, including patients being bridged with mechanical circulatory support, and also patients undergoing concomitant KTx, are being accepted for HTx.
Immunosuppression
Eighty-four percent of the patients received induction therapy with antithymocyte globulin. This was followed by treatment with a calcineurin inhibitor (CNI; cyclosporine or tacrolimus), an antimetabolite (azathioprine, switched to mycophenolate mofetil in 2002), and corticosteroids in all patients. Most patients were discharged on cyclosporine (n ¼ 360; 84%), and those who experienced rejection were switched to tacrolimus (n ¼ 46; 11%).
Determination of Kidney Function
mGFR was determined by the plasma clearance of 51 Cr-EDTA or iohexol 9 measured both before transplantation and at annual checkup visits. The missing data before transplantation in 33 patients (7.9%) were due primarily to ongoing multiorgan failure in the intensive care unit (ICU), including mechanical ventilation and extracorporeal membrane oxygenation, which prevented preoperative mGFR assessment (and thus excluded these patients from our analysis), or during follow-up because of insufficient reporting from local hospitals or emigration. A total of 383 preoperative and 1807 postoperative mGFR measurements were included in the analyses (Figure 1 ).
Management of Early Acute Kidney Failure
All patients were monitored in the ICU with a pulmonary artery catheter and managed with a focus on prevention and treatment of early acute renal 
Stratification of the Study Population
The study population was grouped and analyzed in 4 ways. First, 3 groups were defined according to the era in which the HTx was performed (1988) (1989) (1990) (1991) (1992) -to identify the level at which the preoperative mGFR might negatively affect postoperative survival, and also because these intervals have been used as cutoff levels in previously published guidelines. An mGFR !60 mL/min/1.73 m 2 was considered to indicate normal to mildly reduced renal function. Third, stratification was also done according to the need for early CRRT in the ICU (n ¼ 90) or no need (n ¼ 326). Finally, stratification was done according to the first-year relative decline in mGFR (<5%, 5%-25%, and>25%) after HTx.
ESRD was defined as the need for dialysis or renal transplantation occurring after the first hospital stay, which occurred at a late stage in the majority of cases. The Swedish Renal Registry (www.snronline.se) was used to identify HTx recipients who developed ESRD. In the patients who developed dialysis-dependent ESRD (n ¼ 53; see below), mGFR was not measured annually after initiation of dialysis. Thus, these patients were censored from further analysis, which must be considered when the decline in kidney function is assessed.
Statistical Analysis
Continuous variables are reported as mean AE standard deviation. A P value <.05 was considered statistically significant. The paired Student t test or Wilcoxon signed-rank test have been used when appropriate. The mGFR over time ( Figure 2 ) is shown as aggregated values from each annual visit, without considering competing risks (mortality, dialysis, and kidney Tx). However, the mean drop in mGFR calculated at different time interval (shown in Figure 2 ) are paired results, that is, from patients who survived and had both measurements and did not undergo dialysis or kidney Tx. Survival and time-related event analyses were performed with the Kaplan-Meier method. 11 Censoring was done for retransplantation, development of ESRD, and death. The shaded area around the curves represents the 95% confidence interval. The log-rank test was used to analyze differences between Kaplan-Meier curves. The impact of preoperative renal dysfunction and early postoperative renal dysfunction on mortality was studied with logistic regression. Multivariable Cox regression was applied to identify variables independently associated with mortality or the development of ESRD. Variables with a P value<.10 in univariable Cox regression analysis were selected for further evaluation in a multivariable regression analysis. The assumption of proportional hazards for Cox regression was tested for each covariate and globally using a formal significance test based on the unscaled and scaled Schoenfeld residuals. This assumption was met for all covariates except age ( Table 2 ). The cumulative incidence of chronic dialysis was calculated using competing-risks methods. Death without preceding chronic dialysis was defined as a competing event. A patient with none of those events was censored at the end of follow-up. All statistical analyses were performed using Stata 13.1 (StataCorp, College Station, TX). The Shapiro-Wilk and Shapiro-Francia tests were used to test mGFR for normality. None of our analyses included imputation for missing data.
RESULTS
The patients with preoperative renal dysfunction were older than the patients with mGFR !60 mL/min/ 1.73 m 2 (P < .001) ( Table 1 ). The sex distribution (P ¼ .15) and duration of follow-up (7.7, 8.4 , and 9.6 years, respectively; P ¼ .21) did not differ significantly among the 3 patient groups stratified for preoperative mGFR.
Interestingly, the eGFR value consistently overestimated the mGFR value, especially in patients with low mGFR values. Eight patients underwent concomitant KTx along with HTx, and 15 patients underwent later KTx due to severe chronic renal failure (Table 3) .
Kidney Function After HTx
The long-term changes in kidney function (as measured by mGFR) after HTx are illustrated in Figure 2 . The mean drop in mGFR during the first year post-HTx was 12% compared with pre-HTx values, based on paired results and not adjusting for competing risks. The mean reduction in mGFR during the entire follow-up period was 25%. During follow-up, 129 patients (43%) had an mGFR <30 mL/min/1.73 m 2 recorded on at least at one occasion.
Overall Survival
The 30-day post-transplantation mortality rate was 11%. The actual survival for the whole cohort was 83% at 1 year, 74% at 5 years, 59 at 10 years, 44% at 15 years, and 26% at 20 years (Table 3) , with a median survival of 13 years (95% confidence interval [CI], 11.4-14.9 years). Survival was significantly greater in the later era (2003-2010) compared with both previous eras combined (hazard ratio [HR], 0.55; 95% CI, 0.35-0.86; P ¼ .002, log-rank test) ( Figure E1 ).
Preoperative Predictors of Mortality After HTx
In univariable analyses, age, sex, previous heart surgery, mechanical ventilation, ventricular assist device (VAD) . After HTx, the mGFR as a percentage of baseline mGFR decreased to 88% at 1 year, 77% at 5 years, 69% at 10 years, 57% at 5 years, and 38% at 20 years. During follow up, 129 patients (43%) had an mGFR of<30 mL/min/1.73 m 2 at least once. GFR, Glomerular filtration rate.
therapy, and era of transplantation were significantly associated with 30-day mortality (Table 2) . Interestingly, preoperative mGFR, either grouped (<30;>30-<60;>60) or as a continuous variable, was not predictive of long-term survival in univariable Cox regression analysis (Table 2 ). In the multivariable Cox analysis, only age (HR, 1.03; 95% 
Impact of Dialysis-Dependent Acute Renal Failure Early Post-Htx on Long-Term Survival
Ninety patients (22%) required CRRT early postoperatively in the ICU (Table 3) , and in 81 of these patients (90%), mGFR had been assessed preoperatively. Mean preoperative mGFR was 57 AE 15 mL/min/1.73 m 2 , compared with 65 AE 17 mL/min/1.73 m 2 among the remaining patients (n ¼ 306) who did not require CRRT in the ICU early postoperatively (P <.001). More than one-third (35 of 90; 39%) of the patients who required early CRRT had an mGFR >60 mL/min/1.73 m 2 before transplantation. The patients who received early postoperative CRRT in the ICU (n ¼ 90) had significantly shorter long-term survival compared with those who did not (HR, 1.71; 95% CI, 1.24-2.36; P ¼ .0009) (Figure 3 ). The mortality rate was particularly high during the first weeks and months after HTx; however, those who survived the first critical weeks with CRRT did not seem to have a worse prognosis. Furthermore, renal function recovered in most of these patients, and only 11 of them (12%) later developed ESRD that necessitated maintenance dialysis. Finally, the risk of developing ESRD was not elevated in patients who recovered from early CRRT compared with those who did not require early CRRT after HTx (Figure 4 ).
Preoperative Predictors of Dialysis-Dependent Acute Renal Failure Early Post-HTx
In the univariable logistic regression analysis, previous heart surgery, preoperative VAD, preoperative mGFR, and the era of transplantation were all significantly associated with the need for CRRT in the ICU (Table 4 ). In the multivariable analysis, previous heart surgery (odds ratio [OR], 2.58; 95% CI, 1.38-4.82; P < .001), VAD (OR, 1.70, 95% CI, 1.28-4.82; P < .001), and a mGFR of 30 to 60 mL/min/1.73 m 2 (OR, 2.16; 95% CI, 1.22-3.81; P <.001), as well as mGFR as a continuous variable (OR, 0.96; 95% CI, 1.22-3.81; P <.001), were all independent risk factors for RRT in the ICU, whereas era of transplantation was not.
Decline in Renal Function and Survival at 1 Year Post-Transplantation
The relative decline in mGFR during the first year was divided into 3 strata-<5%, 5% to 25%, and >25%-and analyzed with regard to survival ( Figure 5 ). The logrank test for all 3 groups did not reach statistical significance (P ¼ .073). However, in a univariable Cox regression comparing the 2 other groups with the group with GFR <5% as a reference, those with a decline of 5% to 25% had a nonsignificant effect on long-term survival (HR, 1.14; 95% CI, 0.67-1.93; P ¼ .64), but those with a decline of>25% had a significantly lower survival (HR, 1.62; 95% CI, 1.04-2.53; P ¼ .03), indicating a worse prognosis in patients with an early deterioration of post-transplantation renal function.
Development of Post-Transplantation ESRD and Survival
ESRD was defined as the initiation of maintenance dialysis (hemodialysis or peritoneal dialysis) or a late KTx. FIGURE 3. Survival of patients requiring early postoperative continuous renal replacement therapy (CRRT) in the intensive care unit after heart transplantation (HTx). Mortality was significantly higher in this group than in those without early renal failure, particularly during the first weeks/months (hazard ratio, 1.71; 95% confidence interval [CI], 1.24-2.36; P ¼ .0009, log-rank test). The shaded area around the curves illustrates the 95% CI. HTx, Heart transplantation.
Fifty-three patients (13%) developed ESRD over time after HTx; 34 underwent hemodialysis, and 18 underwent peritoneal dialysis, of whom 13 had a subsequent KTx, and 1 patient underwent KTx without preceding dialysis. The mean preoperative mGFR was 60 AE 18 mL/min/1.73 m 2 (P ¼ .38) for patients who later required hemodialysis, 67 AE 11 mL/ min/1.73 m 2 (P ¼ .49) for those who later required peritoneal dialysis, and 58 AE 16 mL/min/1.73 m 2 (P ¼ .33) for those who later required KTx. The incidence of ESRD was 3.2% (95% CI, 1.8%-5.3%) at 5 years post-HTx, 8.7% (95% CI, 6.0%-12.2%) at 10 years post-HTx, and 15.6% (95% CI, 11.6%-20.1%) at 15 years post-HTx. The likelihood that death had occurred without previous ESRD was 24.5% (95% CI, 20.4%-28.8%) at 5 years, 34.4% (95% CI, 29.5%-39.4%) at 10 years, and 45.4% (95% CI, 39.6%-51.0%) at 15 years. Analysis stratified for era of transplantation did not show any significant difference in the cumulative incidence of ESRD ( Figure 6 ). In the Pepe and Mori test, however, the competing event death without previous ESRD was significantly lower (P <.001) in the most recent period compared with the earlier periods. From the onset of ESRD, median survival was only 2.1 years. The cumulative probability of survival after onset of ESRD was 70% at 1 year, 35% at 5 years, and only 24% at 10 years ( Figure E2 ).
Preoperative Predictors of ESRD
In the univariable analysis, diabetes mellitus, mechanical ventilation, and an mGFR <30 mL/min/1.73 m 2 were significantly associated with the development of ESRD. In the multivariable analysis, however, only mechanical ventilation before HTx (HR, 3.49; 95% CI, 1.36-8.99; P ¼ .009) and diabetes mellitus (HR, 2.39; 95% CI, 1.15-4.99; P ¼ .02) were independent predictors of ESRD (Table 5) , whereas preoperative mGFR was not.
DISCUSSION
The main finding of the present study is that even if preHTx renal function predicted post-transplantation need for CRRT, it was not an independent predictor of either longterm mortality or the development of later ESRD after transplantation. We also found that a decrease in mGFR of>25% during the first year post-HTx, and, in particular, acute renal failure necessitating CRRT post-transplantation, was associated with worse survival. However, we found that early postoperative dialysis-dependent acute renal dysfunction in the ICU was not an independent risk factor for later development of ESRD.
To our knowledge, this is one of the largest single-center studies reported to date systematically evaluating the effects FIGURE 4. Pepe and Mori test comparing the cumulative incidence of events in the patients who received early postoperative continuous replacement treatment (CRRT) in the intensive care unit and those who did not. Those requiring early CRRT had a significantly increased risk for mortality (P ¼ .006), but the difference in later development of end-stage renal disease (ESRD) was not significant (P ¼ .09). Thus, those patients who survive early dialysis-dependent acute renal failure do not have an increased risk for later development of ESRD. The shaded area around the curves represents the 95% confidence interval. HTx, Heart transplantation.
of HTx on postoperative long-term kidney function and the impact of preoperative and postoperative renal dysfunction on survival and the development of ESRD. A strength of this study is that renal function was assessed both preoperatively and postoperatively by mGFR and not by creatininebased eGFR in most other studies. [12] [13] [14] Of clinical importance is the fact that eGFR, used by most other centers, consistently overestimates the true mGFR, regardless of equation used to calculate eGFR. 7 The prognostic utility of pretransplantation renal dysfunction for long-term survival after HTx is controversial. Ostermann and colleagues 13 showed that pretransplantation renal dysfunction (eGFR <50 mL/min) doubled the risk of death within 30 days. In contrast, Odim and colleagues 14 demonstrated that a creatinine clearance <40 mL/min (using the Cockcroft-Gault formula) was not an independent predictor of early or late mortality. Similar to the present study, they identified age of the recipient and pretransplantation use of a VAD as independent predictors of death. A weakness of that study was that pretransplantation renal function was estimated by creatininebased formulas and not actually measured. In a recent large population analysis, including all our adult heart transplant recipients, we found poor agreement between eGFR and mGFR in HTx recipients 7 ; thus the use of eGFR should be avoided, particularly in critical individual treatment decisions.
Regardless of how we stratified preoperative mGFR in the present study, we could not detect a significant relationship between preoperative renal function and longterm mortality by either Kaplan-Meier survival analysis or multivariable regression analysis, supporting the data reported by Odim and colleagues.
14 Furthermore, our data support the statement of the recently updated guideline on listing for HTx 6 that establishes a GFR <30 mL/ min/1.73 m 2 as a relative but not an absolute contraindication, a lower value than in previous guideline recommendations. Even this level may be questioned in selected OR, Odds ratio; CI, confidence interval; HTx, heart transplantation; VAD, ventricular assist device; mGFR, measured glomerular filtration rate.
cases, and patients should not be denied HTx based solely on low eGFR values, given the known poor correlation between eGFR and mGFR; such a decision requires an mGFR.
In contrast to the preoperative mGFR, which did not predict survival in our study, the relative decline of mGFR during the first year predicted shorter long-term survival, indicating the importance of monitoring and preserving kidney function after HTx. The 12% decline in mGFR in the whole cohort during the first year is lower than the 21% we reported for patients managed during the earlier era. 14 Because the decline in GFR is most pronounced during the first year after HTx, 2, 15 improving postoperative management to preserve kidney function is an important area of focus during the first year after HTx.
Previously, but not investigated in the present study, we found no correlation between cyclosporine levels and mGFR at any time point during follow-up, 15 indicating that there are many other factors besides CNI to consider in the early postoperative period. On the other hand, the SCHEDULE study showed that we now have tools available to improve kidney function early after HTx. 16 In this study, patients who started on CNI and low-dose everolimus and subsequently had CNI discontinued, with a parallel dose increase of everolimus at approximately 8 weeks post-transplantation continued up until 1 year, had significantly better kidney function after HTx compared with those who received a standard immunosuppressive regimen. In the everolimus arm of the SCHEDULE study, the mean FIGURE 5. Long-term survival conditioned on 1 year and stratified for different levels of glomerular filtration rate (GFR) decline during the first postoperative year (P ¼ .073, log-rank test). In this analysis, only patients alive after 1 year were included, stratified according to GFR decline. The shaded area around the curves represents the 95% confidence interval. HTx, Heart transplantation. FIGURE 6. Cumulative incidence of chronic renal failure over time stratified for era. The Pepe and Mori test was used to compare cumulative incidences of the competing events end-stage renal disease (ESRD) and death without previous ESRD. The competing event death without previous ESRD was significantly lower (P<.001) in the most recent period compared with earlier periods. The shaded area around the curves represents the 95% confidence interval. HTx, Heart transplantation. mGFR was þ18 mL/kg/1.73 m 2 better than that of the regular CNI group, which is considerably better than the 12% drop in mGFR seen in this study during the first year after HTx. Despite our previous finding of no correlation between the concentration levels for cyclosporine and mGFR, 15 the SCHEDULE study clearly shows that CNI is an important factor involved in the development of renal dysfunction after HTx, and that everolimus should be considered in all patients.
To our knowledge, the utility of pretransplantation mGFR for predicting post-transplantation ESRD has not been evaluated previously. All the patients with ESRD were verified by the Swedish Renal Registry, with 100% national coverage of all dialysis activity, and thus the data are reliable. In the multivariable analysis, pretransplantation mGFR was not a significant risk factor for ESRD after HTx. Many patients in the HTx population will have preoperatively compromised kidney function secondary to heart failure-the so-called ''cardiorenal syndrome, '' 17 which is reversible to some extent post-HTx. This is in contrast to other populations with different etiologies of reduced kidney function with no chance of recovery.
In our cohort, the incidence of early acute renal failure requiring CRRT was high (22%) and had an impact on survival. Previous investigations have reported incidences of early postoperative dialysis-dependent acute renal failure ranging from 6% to 25%. [18] [19] [20] [21] Previous cardiac surgery, high preoperative creatinine, diabetes mellitus, high age, low cardiac output, and low serum albumin have all been reported as independent preoperative risk factors for dialysis-dependent acute renal failure. [18] [19] [20] [21] In the present study, poor renal function and previous cardiac surgery were risk factors for dialysis-dependent acute renal failure, confirming previous studies, as was preoperative use of VAD. Interestingly, and in contrast to other studies in cardiovascular surgery, 22, 23 we did not find an association between early postoperative dysfunction and later development of ESRD in our HTx population. Renal function recovered in 88% of the patients who developed an early postoperative need for CRRT in the ICU. HR, Hazard ratio; CI, confidence interval; HTx, heart transplantation; VAD, ventricular assist device, mGFR, measured glomerular filtration rate.
Furthermore, dialysis-dependent acute renal failure in the ICU was not a risk factor for later ESRD requiring maintenance dialysis.
Experience with patients with end-stage heart failure treated with HTx has accumulated over time, and even though more patients with advanced disease are undergoing HTx, survival haas improved over time, 1, 24 as shown in the present study. To further improve results, an improved intraoperative as well as postoperative kidney protection algorithm is needed. Renal protective immunosuppressive regimes (eg, SCHEDULE study) should be considered in patients with pretransplantation compromised kidney function, not only to improve survival, but also to avoid future chronic kidney disease and, ultimately, dialysis, which is associated with a mean survival of only 2.1 years.
This study has several limitations. First, we are not claiming that preoperative kidney function is of no importance, because patients were selected and the nature of this retrospective report induces biases; however, it describes the clinical reality practiced in our program. To achieve results similar to ours, patients need to be liberally managed with both early and late KTx. Second, our study describes the changes in kidney function over time after HTx, and despite the fact that most patients were followed rigorously both before and after HTx, there were some patients that were too sick (patients with progressive decline requiring ICU in a ventilator, with an intra-aortic ballon pump, or on extracorporeal membrane oxygenation) to investigate with mGFR, thereby excluding some of the sickest patients undergoing HTx. Therefore, selection bias is present in the population to some extent. Third, there has been a slow change over time in not only the use of kidney transplantation in kidney failure but also in the use of CRRT, as well as in the use of VAD as bridge to heart transplantation, the number of high urgencies and many other treatment modalities that affect outcome. Finally, our results may very well be related to a type II error, that the population is too small to allow detection of the true difference, but would show a difference if the populations would be larger (Video 1).
CONCLUSIONS
Pre-HTx renal function was not an independent predictor of long-term mortality after HTx or the development of ESRD in this selected population of patients. Thus, patients with impaired renal function preoperatively had similar long-term survival as patients with normal preoperative renal function; however, caution is encouraged in interpreting these results, which are dependent on both early and late KTx and our local management otherwise. On the other hand, mGFR declined by >25% during the first year posttransplantation and, in particular, those who developed ESRD post-transplantation had a worse prognosis. Early postoperative dialysis-dependent acute renal dysfunction in the ICU was not an independent risk factor for later development of ESRD. FIGURE E1. Survival after heart transplantation was significantly higher in the later time era compared with both previous eras combined (hazard ratio, 0.55; 95% confidence interval [CI], 0.35-0.86; P ¼ .002, log-rank test). The shaded area around the curves represents the 95% CI.
FIGURE E2. Probability of survival after the development of end-stage renal disease after heart transplantation. Survival was 70% after 1 year, 35% after 5 years, and 24% after 10 years. The shaded area around the curves represents the 95% confidence interval.
